Evidence map›Paper›PMID 40770571›Full record

ArticleAnalytical and bioanalytical chemistry2025

Limitations of boronate affinity chromatography for the specific enrichment of fructose-derived early glycation products in protein analytics.

Sebastian Lux, Clara Vogt, Milena Voll, Ralf Hoffmann

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sebastian LuxInstitute of Bioanalytical Chemistry, Faculty of Chemistry, Universität Leipzig, Leipzig, Germany. sebastian.lux@uni-leipzig.de.ORCID http://orcid.org/0000-0003-2686-9348
Clara VogtInstitute of Bioanalytical Chemistry, Faculty of Chemistry, Universität Leipzig, Leipzig, Germany.
Milena VollInstitute of Bioanalytical Chemistry, Faculty of Chemistry, Universität Leipzig, Leipzig, Germany.
Ralf HoffmannInstitute of Bioanalytical Chemistry, Faculty of Chemistry, Universität Leipzig, Leipzig, Germany.ORCID http://orcid.org/0000-0001-9932-5646

Funding

European Fund for Regional and Structure Development (EFRE) 100689097
6 · The paper itself

Abstract

Protein glycation, or non-enzymatic glycosylation, refers to the reaction of reducing sugars with amino groups in proteins to form Amadori and Heyns products for aldoses (e.g., glucose) and ketoses (e.g., fructose), respectively. While Amadori peptides have been well studied after enrichment by boronate affinity chromatography (BAC), it is often assumed that BAC also enriches the isomeric Heyns peptides, although the binding of Heyns rearrangement products seems unlikely due to the very low content of 1,2- and 1,3-cis-diols in their dominant tautomeric forms. For seven different tryptic peptide sequences derived from human plasma digests, we showed that the synthetic glucose-modified Amadori peptides can be enriched by BAC with high recovery rates, while the corresponding fructose-modified Heyns peptides did not bind, independent of the buffers and pH used. Reduction of the carbonyl groups with borohydride, yielding the corresponding hexitol-modified peptides, allowed enrichment of both the former Amadori and, more importantly, Heyns peptides.

Indexed as

Boronic AcidsChromatography, AffinityFructoseGlycation End Products, AdvancedGlycosylationHumansPeptidesBoronic AcidsFructoseGlycation End Products, AdvancedPeptidesAmadori and Heyns peptidesBoronate affinity chromatography (BAC)FructationHexose/hexitol-lysineMultiple reaction monitoring (MRM)

Identifiers

PMID40770571
PMCPMC12431902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.